DCOY Stock Summary and Trading Ideas (Decoy Therapeutics | NASDAQ:DCOY)

Decoy Therapeutics Inc is a pre-clinical stage biotechnology company focused on advancing its pipeline of peptide conjugate therapeutics engineered through its proprietary IMP3ACT platform. The IMP3ACT platform represents a paradigm shift in peptide conjugate drug discovery and manufacturing, leveraging machine learning (ML) and artificial intelligence (AI" tools alongside high-speed synthesis techniques to rapidly engineer, optimize and manufacture peptide conjugates that target serious unmet medical needs. The company manages its business in one operating segment, focused on the discovery and development therapeutics for patients with high, unmet medical needs. Its pipeline programs include: Pan-Coronavirus; and Tripledemic.

Decoy Therapeutics trades on the NASDAQ stock market under the symbol DCOY.

As of October 7, 2026, DCOY stock price climbed to $1.61 with 71,106 million shares trading.

DCOY has a beta of 2.69, meaning it tends to be more sensitive to market movements. DCOY has a correlation of 0.08 to the broad based SPY ETF.

DCOY has a market cap of $1.05 million. This is considered a Sub-Micro Cap stock.

The top ETF exchange traded funds that DCOY belongs to (by Net Assets): VXF, MEDX.

DCOY support price is $1.36 and resistance is $1.74 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that DCOY shares will trade within this expected range on the day.